Target intelligence / Profile preview

Gastric acid secretion and pepsin activity

Molecular classification
Physiological process
01

Overview

Gastric acid secretion and pepsin activity represent the primary digestive functions of the stomach, involving the production of hydrochloric acid by parietal cells and the proteolytic enzyme pepsin by chief cells (StatPearls: Physiology, Gastric Secretion, 2023). This process is tightly regulated by hormonal (gastrin), paracrine (histamine), and neural (acetylcholine) pathways to facilitate protein digestion and eliminate ingested pathogens (NIH: Regulation of Gastric Acid Secretion, 2014). Dysregulation of these processes, particularly excessive acid production or impaired mucosal protection, is central to the pathogenesis of acid-peptic disorders such as gastroesophageal reflux disease (GERD) and peptic ulcer disease (Mayo Clinic: Peptic Ulcer, 2023). While not a single molecular target, this physiological endpoint is the focus of various therapeutic interventions, including proton pump inhibitors (PPIs) and H2-receptor antagonists, which aim to reduce acidity and mitigate mucosal damage (StatPearls: Physiology, Gastric Secretion, 2023). Suppression of these activities is a standard clinical approach for managing hypersecretory states and promoting the healing of gastric and duodenal lesions.

Other names
Gastric acid productionPeptic activityGastric juice secretionGastric acid and pepsin secretion
02

Mechanism of action

Inhibition of the gastric H+/K+-ATPase (proton pump), antagonism of histamine H2 receptors, or chemical neutralization of secreted hydrochloric acid (StatPearls: Physiology, Gastric Secretion, 2023; NIH: Regulation of Gastric Acid Secretion, 2014).

03

Biological functions

DigestionProteolysisAntimicrobial defense
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer diseaseZollinger-Ellison syndromeGastritis
05

Safety considerations

AchlorhydriaHypergastrinemiaIncreased risk of enteric infections (e.g., Clostridioides difficile)Vitamin B12 deficiencyHypomagnesemiaIncreased risk of community-acquired pneumonia
06

Interacting drugs

Omeprazole

7 more in the full profile.

07

Biomarkers

Gastric pHSerum pepsinogen I/II ratioSerum gastrin

Beyond the preview

Go deeper on Gastric acid secretion and pepsin activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric acid secretion and pepsin activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call